Injective price
Injective is trading at $8.73, reflecting a decline of 2.2%, as it tests critical support levels. This price action coincides with the launch of new perpetual futures aimed at private equity markets, which is a significant innovation. Concurrently, Bitcoin experiences a downturn from its recent peak of $110K highs, contributing to ongoing market volatility. The interaction between these developments raises questions about the resilience of Injective and its ability to maintain investor interest amidst changing market dynamics. Traders are closely monitoring these price levels to determine potential future movements and strategies.
